Insulet Corporation 017 Manuale Utente
95
7
■
Important Health-Related Information
For additional information, consult your test strip product infor-
mation sheet.
mation sheet.
WARNINGS!
•
Severe dehydration and excessive water loss may cause false
low results. If you believe you are suffering from severe dehy-
dration, consult your healthcare provider immediately.
low results. If you believe you are suffering from severe dehy-
dration, consult your healthcare provider immediately.
•
Test results below 70 mg/dL mean low blood glucose (hypo-
glycemia).
glycemia).
•
Test results greater than 250 mg/dL mean high blood glu-
cose (hyperglycemia).
cose (hyperglycemia).
•
If you get results below 70 mg/dL or above 250 mg/dL, but
do not have symptoms of hypoglycemia or hyperglycemia
(see Chapter 9, Living with Diabetes), repeat the test. If you
have symptoms or continue to get results that fall below 70
mg/dL or above 250 mg/dL, follow the treatment advice of
your healthcare provider.
do not have symptoms of hypoglycemia or hyperglycemia
(see Chapter 9, Living with Diabetes), repeat the test. If you
have symptoms or continue to get results that fall below 70
mg/dL or above 250 mg/dL, follow the treatment advice of
your healthcare provider.
•
If you are experiencing symptoms that are not consistent
with your blood glucose reading and you have followed all
instructions described in this User Guide, call your healthcare
provider immediately.
with your blood glucose reading and you have followed all
instructions described in this User Guide, call your healthcare
provider immediately.
•
Blood circulation is different between the finger and other
test sites like the forearm, upper arm, and hand. You may see
differences in blood glucose measurements between the
other test sites and your finger after eating, taking insulin
medication, or exercise.
test sites like the forearm, upper arm, and hand. You may see
differences in blood glucose measurements between the
other test sites and your finger after eating, taking insulin
medication, or exercise.
•
You may see changes in blood glucose in blood samples
from the finger sooner than in blood samples from the fore-
arm and other alternate sites. Vigorous rubbing of the alter-
nate test sites before lancing helps to minimize these
differences.
from the finger sooner than in blood samples from the fore-
arm and other alternate sites. Vigorous rubbing of the alter-
nate test sites before lancing helps to minimize these
differences.
•
Do not use during xylose-absorption testing.
•
The lancing device is for individual use only and must not be
shared. Always use a new, sterile lancet; lancets are for single
use only.
shared. Always use a new, sterile lancet; lancets are for single
use only.
•
Objects that may be soiled with blood may then transmit
pathogens. See “Cleaning and disinfecting” in the Appendix
for instructions on how to clean or disinfect your PDM.
pathogens. See “Cleaning and disinfecting” in the Appendix
for instructions on how to clean or disinfect your PDM.
•
“FDA Public Health Notification: Use of Fingerstick Devices on
More than One Person Poses Risk for Transmitting Blood-
borne Pathogens: Initial Communication” (2010) http://
www.fda.gov/MedicalDevices/Safety/AlertsandNotices/
ucm224025.htm.
More than One Person Poses Risk for Transmitting Blood-
borne Pathogens: Initial Communication” (2010) http://
www.fda.gov/MedicalDevices/Safety/AlertsandNotices/
ucm224025.htm.
•
“CDC Clinical Reminder: Use of Fingerstick Devices on More
than One Person Poses Risk for Transmitting Bloodborne
Pathogens” (2010) http://www.cdc.gov/injectionsafety/
Fingerstick-DevicesBGM.html.
than One Person Poses Risk for Transmitting Bloodborne
Pathogens” (2010) http://www.cdc.gov/injectionsafety/
Fingerstick-DevicesBGM.html.